Atlas Trials

Prognostic Biomarkers of Pancreatic Cancer Based on Proteomic Techniques

Clinical trial NCT05289895 · UNKNOWN

Trial details

NCT number
NCT05289895
Sponsor
The Affiliated Hospital of Qingdao University
Status
UNKNOWN
Study type
OBSERVATIONAL
ProteomicsPancreatic CancerPrognostic Biomarkers
Start date
2022-04-01
Primary completion
2023-03-01
Enrollment
220

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.